why choose us

First received: May 29, 2024

Clinical Trial: First-In-Human (FIH) Trial Evaluating the Safety and Tolerability of Single and Multiple Ascending Oral Doses of IRL757 in Healthy Volunteers

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Not Determined

Study Type: INTERVENTIONAL


Official Title: A Prospective, Single-centre, Randomised, Double-blind, Placebo-controlled, Phase I, First-In-Human (FIH) Trial Evaluating the Safety and Tolerability of Single and Multiple Ascending Oral Doses of IR

Brief Summary: This is a Phase 1, First-In-Human study evaluating the safety and tolerability of single and multiple ascending oral doses of IRL757 in healthy volunteers.

Read more